Govt Job: As Research Associate at VIT | Salary Rs. 54,000 pm

VIT was established with the aim of providing quality higher education on par with international standards.

It persistently seeks and adopts innovative methods to improve the quality of higher education on a consistent basis.

The campus has a cosmopolitan atmosphere with students from all corners of the globe. Experienced and learned teachers are strongly encouraged to nurture the students.

Post : Research Associate III – ICMR – SBST

Applications are invited for the Post of Research Associate III (RA-III) for the ICMR Funded Project in School of Bioscience and Technology, Vellore Institute of Technology (VIT).

Project Title : “Machine learning-based model for the diagnosis of SARS-COV2 infection and prediction of strain type using viral genome information”

Qualification for the post : Ph.D (Computer science, Bioinformatics & Computational Biology)

Desirable (if any) : Experience in machine learning studies, excellent script writing in Python and R. Expertise in standard tools of NGS/Transcriptomic analysis. Additionally good communication and writing skills

Stipend :Rs. 54000/month + HRA (For non-NET/GATE candidate, salary will be provided as per the institution norms)

Sponsoring Agency : ICMR
Duration : 2 Years

Principal Investigator : Dr. C. George Priya Doss, Associate Professor, Integrative biology Lab, School of Bioscience and Technology

Co-Investigator : Dr. Gnanasambandan Assistant Professor, School of Bioscience and Technology

Send your resume along with relevant documents pertaining to the details of qualifications, scientific accomplishments, experience (if any) and latest passport size photo etc. on or before (25/04/2022) through online careers.vit.ac.in

• Shortlisted candidates will be called for an interview at a later date which will be intimated by email.

• The selected candidate will be expected to join at the earliest.

Related Posts

Diabetic drug metformin found to act on brain

NEW DELHI:  Cheap, effective and widely trusted, metformin has long been the first choice for treating type 2 diabetes. Now, scientists say the drug works in a way few had…

Hetero debuts semaglutide generic in emerging markets

New Delhi: Hyderabad-based drugmaker Hetero has announced the launch of its generic semaglutide portfolio in emerging international markets. In a phased global push, the company plans to roll out its…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Diabetic drug metformin found to act on brain

Diabetic drug metformin found to act on brain

Hetero debuts semaglutide generic in emerging markets

Hetero debuts semaglutide generic in emerging markets

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

LB Pharma Begins Pivotal Phase 3 Schizophrenia Trial

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Check manufacturing, sale of 26 unapproved drugs, central regulator tells state authority

Stem cell therapy for autism illegal: NMC advisory

Stem cell therapy for autism illegal: NMC advisory

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework

India’s Essential Medicines Prices To Increase Marginally From 1 April Under Annual Pricing Framework